NEW YORK, Aug. 12, 2016 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company") (NASDAQ: TKAI) and certain of its officers. The class action, filed in United States District Court, Southern...
↧
Shareholder Alert: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tokai Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - TKAI
↧